Updated on 2024/05/09

写真a

 
OGAWA Kenichi
 
Name of department
Organization for Health and Well-Being, Health and Counseling Center
Job title
Professor
Concurrent post
Health and Counseling Center(Director)
External link

Education

  • 1998
    -
    2002

    Wakayama Medical University   Wakayama Medical University   内科系  

  • 1990
    -
    1996

    University of the Ryukyus   Faculty of Medicine   School of Medicine  

  • 1985
    -
    1989

    Osaka Kyoiku University   Faculty of Education   特設数学課程  

Degree

  • M.D., Ph.D.   2005

Academic & Professional Experience

  • 2023.04
    -
    Now

    Wakayama University   キャンパスライフ・健康支援センター   教授   センター長

  • 2021.04
    -
    Now

    Wakayama University   保健センター   教授   保健センター長

  • 2017.04
    -
    2021.03

    Kansai University of Health Sciences   Faculty of Health Sciences Department of Acupuncture-Moxibustion and Sports Trainer Sciences   教授

  • 2008.06
    -
    2017.03

    和歌山県立医科大学附属病院紀北分院   内科   助教

  • 2005.08
    -
    2008.06

    和歌山県立医科大学附属病院   内科学第一講座   助教

  • 2002.07
    -
    2005.07

    新宮市立医療センター   内科   医長

  • 2002.04
    -
    2002.06

    和歌山県立医科大学附属病院   内科学第一講座   臨床研究医

  • 1996.04
    -
    1998.03

    和歌山県立医科大学附属病院   臨床研修   診療医

▼display all

Association Memberships

  • -
    Now

    日本臨床分子医学会

  • -
    Now

    和歌山医学会

  • -
    Now

    日本糖尿病学会

  • -
    Now

    日本体質医学会

  • -
    Now

    日本肥満学会

  • -
    Now

    日本病態栄養学会

  • -
    Now

    日本糖尿病合併症学会

  • -
    Now

    日本鍼灸学会

  • -
    Now

    日本糖尿病協会

  • -
    Now

    日本内科学会

  • -
    Now

    日本医師会

  • -
    2023.03

    日本末梢神経学会

  • -
    2023.03

    日本甲状腺学会

  • -
    2023.03

    日本神経学会

  • -
    2023.03

    日本老年医学会

  • -
    2022.03

    日本プライマリー・ケア学会

▼display all

Research Areas

  • Other / Other / Diabetes Mellitus

Classes (including Experimental Classes, Seminars, Graduation Thesis Guidance, Graduation Research, and Topical Research)

  • 2023   Natural disaster and disaster management   Liberal Arts and Sciences Subjects

  • 2023   Outline of Support for Students with Disabilities   Liberal Arts and Sciences Subjects

  • 2023   Risk Management for Students   Liberal Arts and Sciences Subjects

  • 2022   Natural disaster and disaster management   Liberal Arts and Sciences Subjects

  • 2022   Outline of Support for Students with Disabilities   Liberal Arts and Sciences Subjects

  • 2022   Risk Management for Students   Liberal Arts and Sciences Subjects

  • 2021   Risk Management for Students   Liberal Arts and Sciences Subjects

  • 2021   Outline of Support for Students with Disabilities   Liberal Arts and Sciences Subjects

▼display all

Research Interests

  • Diabetic Neuropathy

  • Diabetes Mellitus

Published Papers

  • A literature review of research in Japan focusing on the change of mind of peer supporters themselves

    西谷崇, 森麻友子, 林佐智代, 小河健一, 柳川敏彦, 山本 明弘

    和歌山大学クロスカル教育機構研究紀要   4   70 - 82   2023.03

  • Bilateral atrophy of the extensor digitorum brevis muscle might be a useful sign for diagnosing diabetic polyneuropathy in Japanese men who do not sit in the traditional "seiza" style.

    Shohei Kishimoto, Hideyuki Sasaki, Seigo Kurisu, Kenichi Ogawa, Shohei Matsuno, Hiroto Furuta, Mikio Arita, Keigo Naka, Kishio Nanjo, Takashi Akamizu

    Journal of diabetes investigation   12 ( 3 ) 398 - 408   2021.03

     View Summary

    AIMS/INTRODUCTION: As the extensor digitorum brevis muscle is a small muscle in the most distal part of the legs, its atrophy (EDBA) might reflect symmetric polyneuropathy (SPN). We aimed to clarify the EDBA-related factors and the usefulness of bilateral EDBA detection for diagnosing SPN, especially diabetic SPN (DSPN). MATERIALS AND METHODS: In 1,893 participants from the Japanese general population (investigation I) and 133 established diabetes patients (investigation II), relationships between EDBA and various factors including the traditional sitting style called "seiza'" (kneeling and sitting on one's heels) were investigated. Analyses were carried out by univariate and multivariate analysis, and SPN or DSPN was diagnosed by the criteria of "Probable DSPN" of the Toronto Consensus. The validity of EDBA detection for diagnosing SPN/DSPN was also evaluated. RESULTS: Investigation I: EDBA was more prevalent in women than men (44% vs 20%). Significant EDBA-related factors were aging and seiza habit regardless of sex. Male-specific EDBA-related factors were SPN and known diabetes. In men without seiza habit, EDBA was significantly associated with SPN regardless of diabetes, so EDBA seemed to be a useful sign for diagnosing SPN/DSPN. Investigation II: In men, DSPN was more prevalent in the EDBA group than the non-EDBA group (71% vs 33%). Sensitivity, specificity, positive predictive value and kappa coefficient of EDBA detection for diagnosing DSPN were 44, 87, 67% and 0.323, showing fair agreement. CONCLUSIONS: EDBA detection might be a useful method to screen for distal symmetric polyneuropathy, such as DSPN in men, although the exclusion of individuals with seiza habit is necessary to improve accuracy.

    DOI

  • Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™).

    Kazuhiro Hirayasu, Hideyuki Sasaki, Shohei Kishimoto, Seigo Kurisu, Koji Noda, Kenichi Ogawa, Hiroto Tanaka, Yumiko Sakakibara, Shohei Matsuno, Hiroto Furuta, Mikio Arita, Keigo Naka, Kishio Nanjo

    Journal of diabetes investigation   9 ( 5 ) 1173 - 1181   2018.09

     View Summary

    AIM/INTRODUCTION: Studies on a novel point-of-care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). MATERIALS AND METHODS: For investigation I, 463 non-neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, 'probable DSPN' was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify 'probable DSPN' was evaluated by determining sensitivity, specificity, reproducibility (kappa-coefficient) and the area under the curve of receiver operating characteristic curves. RESULTS: For investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). CONCLUSIONS: A significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF.

    DOI

  • Numbness and paresthesia in bilateral toes and soles, and disproportional sweating restricted to face and trunk are suitable symptoms useful for the diagnosis of diabetic symmetric polyneuropathy.

    Muneki Nakatani, Hideyuki Sasaki, Seigo Kurisu, Hiroyuki Yamaoka, Shohei Matsuno, Kenichi Ogawa, Hiroshi Yamasaki, Hisao Wakasaki, Hiroto Furuta, Masahiro Nishi, Takashi Akamizu, Kishio Nanjo

    Journal of diabetes investigation   2 ( 6 ) 464 - 73   2011.11

     View Summary

    UNLABELLED: Aims/Introduction:  In order to diagnose diabetic symmetric polyneuropathy (DSPN) more simply and accurately, we identified symptoms that correlated with neurological functions and existed more frequently in diabetic than non-diabetic subjects. MATERIALS AND METHODS:   The relationships between 10 symptoms (numbness or paresthesia in toe and sole, numbness in hand, pain in foot or hand, coldness in legs, painful leg cramp, dizziness on standing, sweating restricted to face/trunk and frequent constipation/diarrhea) and clinical background, defined as DSPN and cardiovascular autonomic neuropathy (CAN) by the criteria proposed in the statement of the American Diabetes Association, and seven quantitative nerve function data were evaluated in 593 diabetic patients in Wakayama Medical University Hospital (WMUH). Furthermore, the prevalence of various symptoms was examined by three questionnaires: a WMUH survey (999 diabetic outpatients), a Nationwide survey (1524 male diabetic outpatients under a primary-care physician) and a Control survey (501 non-diabetic subjects). RESULTS:   Bilateral 'numbness in toe and sole', 'paresthesia in toe and sole', 'pain in foot' and 'sweating restricted to face/trunk' were significantly associated with diabetes duration, retinopathy, probable and confirmed DSPN, possible and advanced CAN, and all or six nerve functions. Questionnaire surveys clarified that symptoms that are not rare (>15%) and more frequent in diabetic than non-diabetic subjects were bilateral 'numbness in toe and sole', 'paresthesia in toe and sole', 'coldness in legs', 'dizziness on standing' and 'sweating restricted to face/trunk'. CONCLUSIONS:   Therefore, bilateral 'numbness in toe and sole', 'paresthesia in toe and sole' and 'sweating restricted to face/trunk' are suitable symptoms useful for the diagnosis of DSPN. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00124.x, 2011).

    DOI

  • Pro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patients.

    Shohei Matsuno, Hideyuki Sasaki, Hiroshi Yamasaki, Hiroyuki Yamaoka, Kenichi Ogawa, Muneki Nakatani, Tohru Hamanishi, Asako Doi, Yoshio Nakano, Hisao Wakasaki, Hiroto Furuta, Masahiro Nishi, Takashi Akamizu, Kishio Nanjo

    Journal of diabetes investigation   2 ( 6 ) 474 - 82   2011.11

     View Summary

    UNLABELLED: Aims/Introduction:  We have previously reported that the Pro198Leu missense polymorphism in the glutathione peroxidase 1 (GPx-1) gene was associated with frequent macrovascular disease (MVD). Our goal was to examine whether the GPx-1 genotype is associated with diabetic neuropathy. MATERIALS AND METHODS:   We determined the GPx-1 genotype in 173 Japanese type 2 diabetic patients who received medical interviews, physical examinations, nerve conduction studies, quantitative vibratory perception (QVP), head-up tilt and heart rate variability tests by polymerase chain reaction-restriction fragment-length polymorphism. Diabetic sensorimotor distal symmetric polyneuropathy (DSPN) and diabetic autonomic neuropathy (DAN) were evaluated separately. DSPN and DAN were defined by two or more abnormalities of neuropathic leg symptoms, diminished Achilles tendon reflexes or impaired QVP in toes, and two autonomic dysfunctions, respectively. The association of the GPx-1 genotype with DSPN, DAN, MVD and other clinical manifestations was analyzed. RESULTS:   The prevalence of DSPN, impaired QVP and painful leg cramps in patients having a genotype with Pro/Leu at the codon 198 (Pro/Leu type) was significantly higher than those with Pro/Pro type. As a result of multivariate analyses that contained the GPx-1 genotype as an independent variable, the Pro/Leu type was extracted as a significant risk factor of DSPN, QVP impairment and MVD. The statistical significance did not disappear, even after proteinuria, retinopathy and a history of MVD were introduced as independent variables. In contrast, the GPx-1 genotype was not associated with DAN. CONCLUSIONS:   The Pro198Leu missense polymorphism of the GPx-1 gene might have a common genetic predisposition to DSPN and MVD. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00127.x, 2011).

    DOI

  • Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy.

    Hiroyuki Yamaoka, Hideyuki Sasaki, Hiroshi Yamasaki, Kenichi Ogawa, Takayuki Ohta, Hiroto Furuta, Masahiro Nishi, Kishio Nanjo

    Diabetes care   33 ( 1 ) 150 - 5   2010.01

     View Summary

    OBJECTIVE: Our goal was to ascertain the prevalence of pruritus in diabetic and nondiabetic subjects and the relevance of symptoms, signs, and nerve functions of diabetic polyneuropathy (DPN) of pruritus. RESEARCH DESIGN AND METHODS: A large-scale survey of 2,656 diabetic outpatients and 499 nondiabetic subjects was performed. In diabetic subjects, the relationship between pruritus and age, sex, diabetic duration, A1C, Achilles tendon reflex (ATR), and abnormal sensation in legs was evaluated. In 105 diabetic subjects, nerve conduction studies, quantitative vibratory threshold (QVT), heart rate variability, and a fall of systolic blood pressure at a head-up tilt test (DeltaBP) were performed, and the relationships between pruritus and nerve functions were evaluated. RESULTS: Although the prevalence of truncal pruritus of unknown origin (TPUO) in diabetic subjects was significantly higher than that in age-matched nondiabetic subjects (11.3 vs. 2.9%, P = 0.0001), the prevalence of other pruritus was not different between the two groups. Multiple logistic regression analysis revealed that abnormal sensation and ATR areflexia were independent risk factors for TPUO in age, sex, duration of diabetes, and A1C. DeltaBP in diabetic subjects with TPUO was significantly impaired compared with that in those without TPUO. Larger DeltaBP was identified as a significant risk factor of TPUO independent of other nerve dysfunctions by multiple logistic regression analysis. CONCLUSIONS: TPUO is significantly more frequent in diabetic than in nondiabetic individuals. TPUO is significantly associated with symptoms and signs of DPN, including impaired blood pressure response in a head-up tilt test. TPUO, therefore, might be a newly recognized symptom of DPN.

    DOI

  • Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.

    Hiroshi Yamasaki, Hideyuki Sasaki, Kenichi Ogawa, Takeshi Shono, Shinobu Tamura, Asako Doi, Miyoshi Sasahara, Hiromichi Kawashima, Taisei Nakao, Hiroto Furuta, Masahiro Nishi, Kishio Nanjo

    Diabetes care   29 ( 4 ) 888 - 94   2006.04

     View Summary

    OBJECTIVE: To determine genetic predispositions for diabetic polyneuropathy, we investigated the relationship between the -866G/A polymorphism of uncoupling protein (UCP) 2 and neurological manifestations in 197 type 2 diabetic patients. RESEARCH DESIGN AND METHODS: We first examined whether UCP2 mRNA had been expressed in the dorsal root ganglion (DRG) in four Long-Evans Tokushima Otsuka rats using RT-PCR and electrophoresis. Genotyping of UCP2 promoter polymorphism -866G/A was then performed in 197 unrelated Japanese type 2 diabetic patients, who were subjected to nerve conduction, quantitative vibratory perception, head-up tilt, and heart rate variability tests, by PCR restriction fragment-length polymorphism. The relationships between UCP2 genotype and various nerve functions were analyzed by uni- and multivariable analysis. RESULTS: Expression of UCP2 mRNA was confirmed in rat DRG. Multiple regression analysis clarified the hypothesis that the G/A + A/A genotype was significantly related to decreased motor nerve conduction velocity and impaired blood pressure maintenance on the head-up tilt test. Multiple logistic regression analysis revealed that the G/A + A/A genotypes are a significant risk factor for sensory nerve conduction slowing and orthostatic hypotension. CONCLUSIONS: UCP2 promoter gene polymorphism -866 G/A was significantly associated with nerve conduction slowing and vasomotor sympathetic functions. These findings suggest that the higher UCP2 activity related to the A allele has an energy-depleting effect on peripheral nerve function in type 2 diabetic patients.

  • Prevalence and risk factors for erectile dysfunction in Japanese diabetics.

    Hideyuki Sasaki, Hiroshi Yamasaki, Kenichi Ogawa, Kishio Nanjo, Ryuzo Kawamori, Yasuhiko Iwamoto, Shigehiro Katayama, Masafumi Shirai

    Diabetes research and clinical practice   70 ( 1 ) 81 - 9   2005.10

     View Summary

    We evaluated the prevalence and risk factors for erectile dysfunction (ED) and interest in ED treatment among Japanese men being treated for type 2 diabetes mellitus. Patients (40-79 years; n=1118) completed the 5-item version of the International Index of Erectile Function (IIEF-5), and questions related to interest in ED pharmacotherapy, subjective symptoms of diabetes, and general quality of life. A separate survey completed by physicians examined the relationships between age, diabetic treatments (insulin or oral), symptoms of diabetes (poor glycemic control, microangiopathy), complications of diabetes (hypertension, ischemic heart disease, cerebrovascular disease), and ED. The prevalence of ED in patients with diabetes was 90%, a rate double that of non-diabetic individuals. Multivariate analyses revealed that age, insulin therapy, microangiopathy, hypertension, history of cerebrovascular or cardiovascular disease, leg dysesthesia, dysuria, insomnia, and anorexia all represented significant risk factors for ED. Half of all respondents were interested (29%) or would consider pharmacotherapy for ED (21%). These findings suggest that ED is a significant problem in Japanese men with diabetes, and that specific risk factors increase the prevalence of ED. Furthermore, the survey results expose national attitudes toward treatment of ED.

  • Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice.

    Atsuyo Fujita, Hideyuki Sasaki, Kenichi Ogawa, Kunihisa Okamoto, Shohei Matsuno, Eisaku Matsumoto, Hiroto Furuta, Masahiro Nishi, Taisei Nakao, Takuo Tsuno, Hisaji Taniguchi, Kishio Nanjo

    Diabetes research and clinical practice   69 ( 2 ) 113 - 9   2005.08

     View Summary

    Oxidative stress and the gene expression at the transcriptional level of antioxidant enzymes were investigated in two models of diabetes in mice. We used KKAy mice as a model of obese insulin-resistant diabetes, and streptozotocin-induced diabetic mice (STZ mice) as a model of insulin-deficient diabetes. C57BL mice and saline-injected ICR mice were used as the respective non-diabetic controls. To assess oxidative damage, plasma malonedialdehyde (MDA), urine 8-isoprostane and 8-hydroxy deoxyguanosine (8-OHdG) were measured. The mRNA expression of antioxidant enzymes, superoxide dismutase 1 (SOD-1) and glutathione peroxidase 1 (GPx-1) in the kidney and heart were quantified using a real-time polymerase chain reaction. The KKAy mice demonstrated moderate hyperglycemia and hyperlipidemia, and the STZ mice showed severe hyperglycemia and hypolipidemia. The KKAy mice, but not the STZ mice, showed elevated plasma MDA relative to the non-diabetic controls. Urine 8-isoprostane and 8-OHdG in both diabetic mouse groups increased significantly. The urine oxidative stress markers in the severely hyperglycemic STZ mice were higher than those in the moderately hyperglycemic KKAy mice. Although GPx-1 and SOD-1 showed elevated mRNA expression in the KKAy mice in the kidney and heart, in the STZ mice they did not increase compared to the controls. The compensatory up-regulation of the mRNA expression of antioxidant enzymes may be impaired in the insulin-deficient severely hyperglycemic state.

  • 糖尿病性神経障害の進展様式と予後に及ぼす影響

    小河健一 (Part: Lead author )

    和歌山医学   56 ( 2 ) 91 - 99   2005  [Refereed]

  • Negative pressure suction during blood sampling may reduce the difference in self-monitoring of blood glucose results between fingertip pricking and forearm pricking.

    Keiko Arimoto, Hideyuki Sasaki, Kenichi Ogawa, Hiroshi Yamasaki, Kunihisa Okamoto, Hiroto Furuta, Tadashi Hanabusa, Masahiro Nishi, Taisei Nakao, Kishio Nanjo

    Diabetes care   27 ( 6 ) 1449 - 50   2004.06

  • A suspected case of proximal diabetic neuropathy predominantly presenting with scapulohumeral muscle weakness and deep aching pain.

    K Ogawa, H Sasaki, Y Kishi, H Yamasaki, K Okamoto, N Yamamoto, T Hanabusa, T Nakao, M Nishi, K Nanjo (Part: Lead author )

    Diabetes Res Clin Pract.   54 ( 1 ) 57 - 64   2001

▼display all

Books etc

  • 糖尿病の?(ハテナ)がわかる! イラストBOOK: 「あなた糖尿病ですよ」と告げられたら

    細井 雅之( Part: Joint author,  Work: 小河健一 第2章-2 糖尿病神経障害「見える化」)

    メディカ出版  2022.01 

  • 糖尿病治療のニューパラダイム 第4巻 糖尿病に合併する病態とその治療

    宇都宮一典, 編集委員, 綿田裕孝, 編集委員, 松田昌文, 編集委員, 池上博司, 編集委員( Part: Joint author,  Work: 栗栖清悟、小河健一、佐々木秀行:4)有痛性神経障害の薬物療法 4. 糖尿病神経障害 第4章 慢性合併症の病態とその治療しくみ。196-202)

    医薬ジャーナル  2019.03 

  • 糖尿病の病態生理イラスト図鑑: 病気のしくみ・合併症・治療による変化がわかる (糖尿病ケア2019年春季増刊)

    細井 雅之 編集( Part: Joint author,  Work: 小河健一、佐々木秀行 ③糖尿病神経障害が起こるしくみ、第2章糖尿病合併症のしくみ。88-91)

    メディカ出版  2019.02 

  • 糖尿病ケア2016年春季増刊 ダウンロードでそのまま使える! 患者さんがみるみる変わる! 魔法の糖尿病患者説明シート50+α 唱えて変身! 魔法の言葉つき♪

    細井 雅之 編集( Part: Joint author,  Work: 小河健一、佐々木秀行 60-63)

    メディカ出版  2016.03 

  • 糖尿病診療マスター 2014年増刊号 Brush Up! CDE 糖尿病合併症事典

    ( Part: Joint author,  Work: 小河健一、佐々木秀行 脳神経障害(単一神経障害)60-63)

    医学書院  2014.04 

  • 糖尿病プラクティス 糖尿病神経障害 -最新の知見と薬剤選択-

    ( Part: Joint author,  Work: 小河健一、佐々木秀行 糖尿病神経障害‐概念,診断,病期分類,治療‐ 419-427)

    医歯薬出版  2013.07 

▼display all

Misc

  • Clinical Features of Diabetics with Orthostatic Hyportension-Sex Difference, Risk Factors and Mortality-

    Sasaki Hideyuki, Yamamoto Naoya, Okamoto Kunihisa, Ogawa Kenich, Yamasaki Hiroshi, Kishi Yutaka, Naka Keigo, Sanke Tokio, Nanjo Kishio

    Journal of Japan Diabetes Society ( THE JAPAN DIABETES SOCIETY )  42 ( 11 ) 917 - 925   1999

     View Summary

    Prevalence, clinical characteristics and risk factors of orthostatic hypotension (OH) were assessed in 600 diabetic patients aged 20 to 65 years.<BR>The influence of OH on mortality was also examined in 320 diabetic patients, who were followedup 1 to 15 years (average 5.1 years) later with nerve function testing. OH was judged by an orthostatic fall in systolic blood pressure of 30 mmHg or more, or by a systolic pressure of less than 80mmHg after standing. The results were as follows:(1) The prevalence of OH was 18%.(2) Half of the patients with OH were asymptomatic.(3) OH was observed more frequently in patients with long duration diabetes, severe microangiopathy, low body mass index, high blood pressure and imparired nerve functions, including nerve conduction slowing, decreased heart rate variability and an increased vibratory perception threshold.(4) The prevalence of OH in males was higher than in females especially in patients more than 50 years old.(5) The mortality of the OH patients (29.2/ 1, 000 person-year) was significantly higher than that of the non-OH patients (4.4/1, 000 personyear), and was significantly higher than that of the microangiopathic non-OH patients (4/1, 000 person-years), whose severities of retinopathy and nephropathy were equal to OH patients.(6) Half of the OH patient mortalities had suffered sudden unexpected deaths.

    DOI

Conference Activities & Talks

  • 痛覚閾値は加齢による上昇が少なく糖尿病では早期から低下する

    小河 健一, 栗栖 清悟, 岸本 祥平, 佐々木 秀行, 廣西 昌也, 羽野 卓三

    第30回日本老年医学会近畿地方会  2019.11.16  

  • 表皮内神経終末痛覚閾値の 糖尿病神経障害診断における有用性

    小河健一, 岸本祥平, 栗栖清悟, 松野正平, 佐々木秀行, 古田浩人, 西 理宏, 南條輝志男, 赤水尚史

    第56回日本糖尿病学会近畿地方会  2019.11.09  

  • 表皮内神経終末痛覚閾値(PINT)は糖尿病早期から 上昇し、小径神経線維の指標として有用と思われる -地域健康診断での検討-

    小河健一, 岸本祥平, 栗栖清悟, 松野正平, 佐々木秀行, 古田浩人, 西 理宏, 南條輝志男, 赤水尚史

    第34回日本糖尿病合併症学会  2019.09.27  

  • 表皮内神経終末痛覚閾値(PINT)上昇に関連する臨床因子 -地域健康診断での検討-

    小河健一, 栗栖清悟, 岸本祥平, 野田幸治, 佐々木秀行, 山根木美香, 古田浩人, 西 理宏, 赤水尚史, 南條輝志男

    第67回日本体質医学会総会  2017.09.03  

Instructor for open lecture, peer review for academic journal, media appearances, etc.

  • 医師

    2024.03.16

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて、人工透析の管理を行う。

  • 医師

    2024.03.09

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2024.03.08

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2024.02.10

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2024.01.20

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2024.01.07

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2024.01.06

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.12.09

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.11.04

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.10.28
    -
    2023.12.23

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.10.07

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.09.24

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.09.23

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.08.05

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.07.22
    -
    2023.08.26

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.07.02

    医療法人やまびこ会

     View Details

    内科診察医、透析管理医

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.04.29

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う

  • 医師

    2023.04.01
    -
    2024.03.31

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 非常勤医師

    2023.04.01
    -
    2024.03.31

    学校法人 関西医療学園

     View Details

    内科診療

    大学附属診療所において、内科の診察を行う。

    午前 9:00~12:00
    午後 13:30~15:30

  • 医師

    2023.04.01
    -
    2023.06.30

    医療法人やまびこ会

     View Details

    非常勤医師

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2023.03.25

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.03.11

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.03.10

    医療法人やまびこ会

     View Details

    非常勤医師

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 講演者

    2023.02.16

    第一三共株式会社

     View Details

    糖尿病性神経障害

    2023年2月16日(木)19:00~の講演会「New Trends in Diabetic NeuropathyDiabetic 」
    において糖尿病性神経障害の講演を実施する。

    開催場所:大阪府泉佐野市りんくう往来北1 スターゲートホテル関西エアポート4階「高砂」

  • 医師

    2023.02.11

    医療法人やまびこ会

     View Details

    透析管理

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2023.01.21

    医療法人やまびこ会

     View Details

    内科診療、透析管理

    本クリニックにおいて内科診察および人工透析の管理を行う。

  • 医師

    2022.12.03

    医療法人やまびこ会

     View Details

    非常勤医師

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2022.11.03

    医療法人やまびこ会

     View Details

    透析管理

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2022.06.11

    医療法人やまびこ会

     View Details

    内科診療、透析管理

    本クリニックにおいて内科診察および透析の管理を行う。

  • あん摩マッサージ指圧師、はり師、きゅう師国家試験委員

    2022.04.01
    -
    2024.03.31

    (公財)東洋療法研修試験財団

     View Details

    国家試験問題作成

    あん摩マッサージ指圧師、はり師、きゅう師国家試験問題作成

  • 医師

    2022.04.01
    -
    2023.03.31

    医療法人やまびこ会

     View Details

    透析管理医

    本クリニックにおいて人工透析の管理を行う。

  • 医師

    2022.03.11

    医療法人やまびこ会

     View Details

    非常勤医師

    本クリニックにおいて内科診察および透析の管理を行う。

  • 非常勤講師

    2021.10.02
    -
    2021.11.20

    学校法人 関西医療学園

     View Details

    医療を志す学生への教育

    関西医療大学 保健医療学部 はり灸・スポーツトレーナー学科4年生を対象とした「総合演習Ⅱ」の授業

  • 医師

    2021.07.30

    医療法人やまびこ会

     View Details

    非常勤医師

    本クリニックにおいて内科診察および透析の管理を行う。

  • 非常勤医師

    2021.04.01
    -
    2023.03.31

    学校法人 関西医療学園

     View Details

    内科診療

    本学附属診療所において、内科の診察を行う。

    午前 9:00~12:00
    午後 13:30~15:30

▼display all

Committee member history in academic associations, government agencies, municipalities, etc.

  • 学術評議員

    2019.05.24
    -
    Now
     

    日本糖尿病学会

     View Details

    糖尿病

    日本糖尿病学会の評議員として、学会の運営および糖尿病の予防・治療、合併症余郷・治療、指導などを行う。

  • 腎症重症化予防 担当医

    2018.09.01
    -
    Now
     

    日本糖尿病学会

     View Details

    糖尿病

    日本糖尿病学会の腎症重症化予防担当医として、地域住民に対する腎症重症化予防に対する啓蒙、治療に努める。

  • 理事(会長推薦)

    2017.04.01
    -
    Now
     

    和歌山県糖尿病協会

     View Details

    糖尿病、患者会

    糖尿病の患者会である日本糖尿病協会の和歌山支部において、糖尿病患者・家族への療養支援、地域への啓蒙・教育活動、和歌山糖尿病療養指導士の育成などに関わっている。

  • 学術評議員

    2014.01
    -
    Now
     

    日本病態栄養学会

     View Details

    糖尿病

    日本病態栄養学会の評議員としいて、学会の運営に協力し、病態栄養の解明に取り組む。